← Open Payments lookup

WENDI KONOMOS: Open Payments

NPI 1699965533 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$609 in 32 payments from 11 companies in 2025. Trend: 2023 $635 · 2024 $495 · 2025 $609

Food & beverage: $609
CompanyPaymentsAmount
ABBVIE INC.15$181
Boehringer Ingelheim Pharmaceuticals, Inc.5$173
Vanda Pharmaceuticals Inc.2$57
Melinta Therapeutics, LLC2$45
Exact Sciences Corporation2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
SANOFI-AVENTIS U.S. LLC1$24
Gilead Sciences, Inc.1$20
Axsome Therapeutics, Inc.1$18
Novo Nordisk Inc1$16

Products named: JARDIANCE, VRAYLAR, FANAPT, QULIPTA, Rezzayo, CAPLYTA, DALVANCE, TZIELD.

Industry payments across TX — which companies pay providers there.